TriSalus Life Sciences, Inc. (TLSI) Reports Q4 Loss, Tops Revenue Estimates

TriSalus Life Sciences, Inc. (TLSI) came out with a quarterly loss of $0.35 per share in line with the Zacks Consensus Estimate. This compares to loss of$1.56 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this company would post a loss of $0.36 per share when it actually produced a loss of$0.40, delivering a surprise of -11.11%.Over the last four quarters, the company has not been able to surpass consensus EPS estimates.TriSalus Life Sciences, ...